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Abstract: Diseases in the ocular posterior segment are a leading
cause of blindness. The surgical skills required to treat them are
at the limits of human manipulation ability, and involve the risk
of permanent retinal damage. Instrument tethering and design
limit accessibility within the eye. Wireless microrobots suture-
lessly injected into the posterior segment, steered using mag-
netic manipulation are proposed for procedures involving
implantation. Biocompatibility is a prerequisite for these proce-
dures. This article investigates the use of polypyrrole- and gold-
coated cobalt-nickel microrobots. While gold has been used in
ocular implants, no ocular implantation involving polypyrrole is
reported, despite its well-established biocompatibility proper-
ties. Coated and uncoated microrobots were investigated for
their corrosion properties, and solutions that had contained
coated and uncoated microrobots for one week were tested for
cytotoxicity by monitoring NIH3T3 cell viability. None of the
microrobots showed significant corrosion currents and corro-
sion potentials were as expected in relation to the intrinsic nobil-
ity of the materials. NIH3T3 cell viability was not affected by the
release medium, in which coated/uncoated microrobots were
stored. In vivo tests inside rabbit eyes were performed using
coated microrobots. There were no significant inflammatory
responses during the first week after injection. An inflammatory
response detected after 2 weeks was likely due to a lack of
longer-duration biocompatibility. The results provide valuable
information for those who work on implant technology and bio-
compatibility. Coated microrobots have the potential to facilitate
a new generation of surgical treatments, diagnostics and drug-
delivery techniques, when implantation in the ocular posterior
segment will be possible. VC 2016 Wiley Periodicals, Inc. J Biomed
Mater Res Part B: Appl Biomater 00B: 000–000, 2016.
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sion; cell culture; rabbit model
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INTRODUCTION
Diseases in the posterior segment of the eye, such as age-
related macular degeneration and diabetic retinopathy, affect
the ocular function of over 8 million people in the USA
alone.1,2 These disorders are the most common causes leading
to permanent vision loss in the industrialized countries. They
are currently treated with instruments that require the visual
and tactile perception of a surgeon. The surgical skills
required are at the limits of human capabilities, and many ret-
inal treatments risk permanent damage to the retina. Further-
more, accessibility within the eye is limited by instrument
tethering and design.3–5 Minimally invasive, wirelessly con-
trolled and powered microrobots6 are alternatives proposed
for use in ocular medicine. Injected suturelessly into the eye5
[Figure F11(A, B)], they can be precisely steered with 5 degrees
of freedom using external magnetic ﬁelds generated by a mag-
netic manipulation system.4 The system controls the forces
and torques that the microrobot applies during surgery, and
the microrobot’s location is tracked visually through the
pupil. The microrobot can precisely access regions of the eye
that conventional tools cannot reach.
Several potential ophthalmic applications, such as ﬂuores-
cent dye-based oxygen sensing7 for diagnosis of retinal hypoxia,
retinal vein puncturing8,9 for precisely targeted injections, intra-
vitreal micromechanical measurements,10 and drug delivery11,12
for retinal diseases, have been demonstrated using microrobots.
Unlike conventional ophthalmic drug-delivery procedures (i.e.,
with tablets, eye drops, and lotions) that must be administered
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frequently to maintain the required therapeutically relevant tis-
sue levels of the drugs, implantable steerable microrobots offer
an alternative strategy as therapeutic reservoirs. Drugs can be
released directly to the target during an extended period while
minimizing possible side effects to surrounding tissues. The
drug can be encapsulated9,11 inside the microrobot or included
on a multi-layered functional surface.12
In ophthalmic applications, the microrobot can be
implanted in the posterior segment of the eye in the proximity
of ocular structures needing treatment/diagnosis. A targeted
drug-delivery4,11,12 application to treat age-related macular
degeneration requires implantation. Vessel-targeted injec-
tions with thrombolytics for central retinal artery and vein
occlusions are further potential applications. The microrobots
can be steered and oriented during a procedure using a mag-
netic manipulation system4 designed for the microrobots.
They can be implanted in a desired location. After implanta-
tion the microrobots can be controllably retrieved from the
eye5 using the same manipulation system. The system is capa-
ble to align them with and maneuver them toward a custom-
made “reverse” injector with a magnetic shaft,5 and the shaft
can be used to pull the microrobot inside the injector. A criti-
cal factor for the success of these new therapies is the bio-
compatibility of the microrobots, which is a function of shape,
size, the physical, chemical and surface properties of the used
materials, the interaction of the microrobots with speciﬁc
regions of the eye, the presence of an ocular immune
response, and duration of the interaction.
Progress on ocular biomaterial research is demonstrated
by the widespread use of contact lenses, and the frequent
use of intraocular lenses implanted in cataract surgeries.
This has spurred research on biomaterials for implantable
devices such as glaucoma ﬁltration devices, scleral buckles,
and keratoprostheses. In contrast, research on biomaterials
for the posterior segment is still in early development as
posterior segment implants themselves are a relatively new
phenomenon.13 Several metals and polymers are used as an
implant material and as an implant coating.
The typical metals used in ophthalmic surgery instru-
ments are titanium and stainless steel, because their acute
ocular toxicity is negligible.14 Additionally, new suturing tech-
niques in anterior segment surgery have used nitinol intraoc-
ular clips that have not demonstrated any short-term toxicity
in mini-pig eyes.15 Titanium tacks have exhibited long-term
biocompatibility in rabbit eyes and may provide a permanent
and stable option for anchoring intraocular implants in the
posterior segment.16 In several medical applications, titanium
coating provides superior surface adhesion properties and
microsurface smoothness in vitro and in vivo.16 However,
functionalization of these metals can be challenging.
Gold17,18 (Au) is a good candidate for ocular implant
coatings due to its nobility, inert nature, resistance against
bacterial colonization, as well as its potential functionaliz-
ability. Used also as an adhesion layer, Au enables further
electrodeposition of other functional coatings.
Two types of polymer materials, erodible and nonerodible,
have been used in intraocular implants that are already on the
market or close to commercialization. One of the most long-
standing implants, Ozurdex,19 consists almost entirely of bioer-
odible poly(lactide-co-glycolide) (PLGA). Although the by-
products of bioerosion (water and carbon dioxide) are nontoxic,
acidiﬁcation during degradation is detrimental for biological
function (i.e., protein delivery). The Retisert20 implant, approved
by the FDA for treating uveitis, is composed of a combination of
nondegradable poly(vinyl alcohol) (PVA) and nonerodible sili-
cone elastomer held together by silicone glue. The Retisert
implant therefore has to be surgically retrieved after implanta-
tion. Iluvien is a another nondegradable insert made from poly(i-
mide) with PVA caps to control the rate of drug release21 and is
in clinical use to treat diabetic macular edema.
New, better tunable and functionalizable polymers are
needed for future ocular applications. Polypyrrole (Ppy) has
well-established long-term biocompatibility with a variety of
cell types (e.g., as neural prosthetics22). It is the best-
characterized intrinsically conducting polymer due to its
versatile and tunable properties, and also exhibits mechani-
cal stability and ease of synthesis. Ppy can be prepared as a
conformal functional coating onto microstructures of differ-
ent shapes. Its surface properties can be electrochemically
tuned due to its property of redox switching.23
In this article, cylindrical microrobots made of magnetic
cobalt-nickel (CoNi) alloy (allowing magnetic manipulation),
coated with Au and Ppy, are explored for their biocompatibility
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FIGURE 1. A: A Ppy-coated microrobot to be injected suturelessly via a
23G needle into a living rabbit eye. The microrobot is loaded into the
needle using suture forceps with flat tying platform. The photograph is
rotated and mirrored for clarity. B: The SEM image shows a typical
cylindrical CoNi microrobot as prepared. The inset shows a magnified
detail of one end. Microrobots were coated with Au and with Ppy, which
are shown in the following SEM images. C: Au coating on the surface of
a CoNi microrobot. D: Ppy coating prepared on a Au-coated microrobot.
Imaging was carried out using a Zeiss Ultra 55.
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in ocular applications. The corrosion performance of the coated
(Au and Ppy) and uncoated microrobots (as-prepared CoNi) is
investigated. Hank’s balanced salt solution (HBSS) was used
for modeling the corrosion properties of the vitreous to mimic
its primary component. HBSS is a standard physiological solu-
tion, used as anterior eye chamber ﬂuid replacement, as intra-
ocular irrigation ﬂuid and a typical model used in ophthalmic
toxicology studies.24 In vitro cell viability as determined by cell
proliferation of NIH3T3 ﬁbroblasts was performed to investi-
gate potential release of metal ions or leachables from coated
and uncoated microrobots for implantation after 1 week of
storage in solution. Finally, in vivo trials with coated microro-
bots [Figure 1(A, B)] were carried out inside the eyes of living
New Zealand white rabbits with a follow-up of 49 days.
MATERIALS AND METHODS
Fabrication of the microrobots
The fabrication of tubular microrobots [Figure 1(B)] is
described in detail elsewhere.9 The outer diameter (OD) of all
the microrobots was restricted to 300610 mm to satisfy the
size requirements of the inner diameter (ID) of the 23G nee-
dle used for sutureless injection into the ocular vitreous. Solid
CoNi microrobots were fabricated on a Au wire (250 mm in
diameter) to provide the electrical connection required in the
electrochemical corrosion tests. Cell tests were carried out
with similar microrobots. A CoNi layer 25 mm thick was
deposited on the wire to obtain the ﬁnal OD of 300 mm. For in
vivo studies, the microrobots were fabricated on a thinner
sacriﬁcial aluminum wire (125 mm in diameter; pre-coated
with 0.2-mm-thick Au in bright electroless Au bath at 908C for
12 min, Transene company, Danvers, MA). The thinner wire
allowed for preparation of sufﬁcient magnetic material (CoNi)
for magnetic manipulation. Hence, CoNi 88 mm thick was elec-
troformed on the wire to obtain the ﬁnal OD of 300 mm. Sub-
sequently, the aluminum wire was etched, and only the
electrolessly prepared Au coating remained covering the hol-
low interior of the microrobot. Microrobots were then coated
for the tests. Their surface after coating with Au and Ppy is
shown in Figure 1(C, D), respectively.
Preparation of the coatings
Prepared as shown in TableT1 I, solid microrobots without
coating (controls) and with coatings from two different
materials (Au and Ppy) (FigureF2 2), were used in corrosion
and in cell tests. The microrobots used in vivo had their
outer surface coated with Ppy and their inner surface
coated with Au (i.e., hollow interior used as a potential drug
reservoir). The same coating methods were used as with
the solid microrobots. The Au layer serving as a potential
ﬁnal coating or as an adhesive layer for further coatings
was prepared using two methods. Au coating type I was
prepared by electroless deposition by immersing an implant
into a bright electroless Au bath (from Transene company,
Danvers, MA) at 908C for 12 min. Au coating type II [Figure
1(C)] was prepared by electrodeposition in a Au bath with a
formulation described by Jang et al.25 Both types, 0.2-mm-
thick coatings, were compared in corrosion and in cell tests.
The use of Au enabled subsequent electrodeposition of Ppy
on the CoNi microrobots.
Ppy [Figure 1(D)] was galvanostatically electropolymer-
ized on the Au-coated microrobots. In preparing the Ppy coat-
ing,23 an electroplating bath containing 0.1 M sodium
dodecylbenzene sulfonate (NaDBS) and 0.1 M pyrrole was
used. A current density of 1 mAcm22 was applied on the
microrobot for 10 min to get a thickness of approximately 3
mm. The microrobot served as the working electrode (WE)
and a platinum-coated titanium plate as the counter electrode
(CE), together with a reference electrode (RE). A double junc-
tion Ag|AgCl RE was used with 3 M KCl inner solution and a
0.1 M NaDBS outer solution.
The microrobots with Ppy surfaces were cathodically
doped to gain antibiofouling23 properties for the cell and
for the in vivo tests. Cathodic doping was performed in a
0.1 M NaDBS aqueous solution with the same electrode
arrangement employed in the Ppy electropolymerization.
The doping was carried out by cyclic voltammetry (3 cycles;
scan rate of 10 mVs21) between 0 V and 20.7 V.
Corrosion tests
HBSS (Sigma, H8264-500 mL) was used to evaluate the cor-
rosion properties of the microrobots’ materials and coatings.
The electrochemical cell equipment used for the corrosion
tests is presented in Supporting Information (Figure S1).
The cell ﬁlled with 100 mL of HBSS was thermostated at
body temperature (378C). Each microrobot was immersed
2 mm into the HBSS using a micropositioner (SmarAct
GmbH, HCU-3D). Three electrodes were immersed into the
HBSS (WE, CE, and RE). The microrobot was used as the
WE. A platinum-coated helical titanium wire was used as
the CE for applying a homogeneous electric ﬁeld around the
microrobot (see Supporting Information Figure S1). The RE
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FIGURE 2. The cross-sectional view of a solid microrobot, that is,
coated with Au and Ppy.
TABLE I. Four Different Types of Microrobot Surfaces
Prepared.
Types Surface
Uncoated Electroformed CoNi
Au type I Electrolessly deposited Au
Au type II Electrodeposited Au
Ppy Electrodeposited Ppy
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was a double-bridge (Ag | AgCl (3 M KCl)) ﬁlled with HBSS in
the outer bridge. The samples were subject to an open-circuit
potential (OCP) for 5 h in order to determine the steady-state
potential. Then, potentiodynamic polarization tests were per-
formed by scanning at a scan rate of 0.1 mVs21 from 300 mV
below the obtained OCP value toward more positive values up
to 300 mV above the OCP. Between three and six replicas per
microrobot type were tested. A paired t test with Bonferroni
correction for the comparison of multiple groups was used to
validate the signiﬁcance (95% conﬁdence level) of the differ-
ences between the microrobot types regarding their corrosion
potential. The specimens were subjected to SEM imaging
(Merlin Zeiss), energy dispersive X-ray (EDX) and X-ray pho-
toelectron spectroscopy (XPS) analysis after the corrosion
tests. XPS analyses were carried out on a PHI 5500 Multitech-
nique System (from Physical Electronics) spectrometer,
equipped with a monochromatic X-ray source (KaAl line with
energy of 1486.6 eV and 350 W).
Fibroblast proliferation assay
Prior to the experiments, the microrobots (Figure 2) were
sanitized for >12 h in 70% ethanol and were washed three
times with phosphate buffered saline (PBS) containing 1%
Penicillin/Streptomycin antibiotics (Biochrom A2212) in an
Eppendorf tube. They were stored in 400 mL of PBS contain-
ing 1% Penicillin/Streptomycin as a release medium for one
week at room temperature. NIH3T3 ﬁbroblasts (ATCC-Num-
ber CRL-1658, ATCC, Manassas, VA), harvested from subcon-
ﬂuent monolayers, were incubated in 25 cm2 culture ﬂasks
at 378C and 5% CO2. The growth medium (DMEM) included
10% heat-inactivated fetal bovine serum (Invitrogen 10270)
and 1% Penicillin/Streptomycin. NIH3T3 ﬁbroblast prolifera-
tion was characterized by the mitochondrial activity of living
cells using a tetrazolium dye (MTT) based colorimetric assay
as previously described in Sivaraman et al.23 5000 ﬁbroblast
cells were seeded in 100 mL growth medium in a 96-well
plate. On the next day 100 mL of PBS, in which the different
types of microrobots had been stored for 7 days, was added
for 24 h prior to analysis. The cell proliferation was then nor-
malized with the mitochondrial activity of the cells cultured
in pure PBS with 1% Penicillin/Streptomycin (i.e., control). A
minimum of four samples was used for in vitro cell experi-
ments. The MTT assay is a common and standard assay to
assess cell proliferation as readout for toxicity and is routinely
performed with antibiotics in the test medium.23,26 Although
it is generally possible to perform the assay without antibiot-
ics, they were used in the ﬁrst toxicity screening for monitor-
ing potential adverse effects of the microrobots reported
here. The control group was therefore treated similarly with
PBS containing 1% antibiotics and set to 100% viability.
In vivo rabbit experiments
The microrobots were washed in an acetone bath, then in
an isopropanol-ethanol (1:1) solution and ﬁnally in DI water
prior to injecting into the in vivo rabbit eyes (healthy New
Zealand white rabbits, 9 month-old female). The microro-
bots were subsequently autoclave sterilized. Prior to the
injection the rabbits were anesthetized. Animal housing,
anesthetic and surgical procedures, and post-procedure
examinations were performed in laboratory animal facilities
at the Vetsuisse Faculty, University of Zurich.
Two groups of rabbits were used (Groups A and B) with
six individuals in each group. The rabbits in Group A,
received a microrobot injected into a randomly assigned eye
(referred to as Group A1). The fellow eyes of these rabbits
served as internal controls (referred to as Group A0). Group
B served as control group for the microrobot injections.
Rabbits in Group B received a sham injection into a ran-
domly assigned eye (referred to as Group B1). The fellow
eyes of these rabbits served as internal controls (referred to
as Group B0).
Sutureless injections into the rabbit eyes were carried
out via a standard 23G needle through the pars plana of the
ciliary body into the vitreous (see Figure F33). Successful
injections into the right eye were performed at the 10–11
o’clock position and into the left eye at the 1–2 o’clock posi-
tion. The maximum distance between the injection site and
internal limbus observed during injection was 1 mm. Pre-
liminary ex vivo injection experiments in rabbit eyes
obtained from slaughter demonstrated this distance as opti-
mal to ensure safe insertion of the microrobots into the cen-
tral vitreous while avoiding damage to critical tissues (e.g.,
lens and retina). In Group A1, the microrobots were injected
using 0.1 mL hyaluronic acid (HA, Acrivet Biovisc 1.2%),
which helped to push the robot away from the needle tip.
For each rabbit receiving an intravitreal microrobot, there
was a control rabbit (Group B1) that received a sham-
injection of 0.1 mL HA only, which was identical in all
aspects other than the insertion of a microrobot. The nonin-
jected eyes (i.e., fellow eyes) of the rabbits served as inter-
nal controls (Groups A0 and B0). Post-injection medications
included 0.2 mg Buprenorphine (s.c., for analgesia during
the ﬁrst day), 5 mg/kg Enroﬂoxacin as antibiotic and
0.3 mg/kg BW Meloxicam for anti-inﬂammatory purposes
for 10 days. The eyes were followed clinically for 49 days
after implantation was performed. The microrobots were
manipulated (i.e., rotated and moved a maximum distance
of their body length) at 28 days after implantation and the
effect of robot manipulation was observed.
The condition of the eyes was examined for inﬂammatory-
response related changes (see Supplementary material: Pro-
tocol for ophthalmic examination pre and postimplantation of
intravitreal steerable inserts). Slit lamp biomicroscopy of the
anterior segment using a hand-held slit lamp (Kowa SL-15)
with 10/163 magniﬁcation was used. Indirect ophthalmos-
copy of the posterior segment (i.e., vitreous, retina, and optic
nerve) was performed using a Heine Omega 200 indirect oph-
thalmoscope and 20, 30, and 40 diopter condensing lenses.
Tonometry was used to determine intraocular pressure (IOP)
using a calibrated rebound tonometer (TonoVet). A modiﬁed
McDonald-Shadduck27 score system (see Supplementary
material: Ocular irritation scoring scale based on modiﬁed
McDonald-Shadduck score system) was used to grade inﬂam-
matory changes in the anterior and posterior segment. Oph-
thalmic examinations were carried out as described above
when the animals arrived at the research facility, as well as
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one day prior to the planned intervention with the microrobot
implantation or sham injections. Follow-up examinations
were organized every day during the ﬁrst three days after the
injection, and subsequently, once every week until euthanasia
(day 50). Immediately after euthanasia the eyes were surgi-
cally removed and placed in a modiﬁed Karnovsky’s ﬁxative
(Paraformaldehyde 2%, Glutaraldehyde 2.5% in 0.1M Sodium
Phosphate buffer) for 24 h at room temperature. The eyes
were then placed in a 0.1M NaP buffer solution for shipment
to the Comparative Ophthalmic Pathology Laboratory of Wis-
consin (University of Wisconsin-Madison) where the eyes
were examined histopathologically by light microscopy.
Data were evaluated using descriptive statistics. No sta-
tistical comparisons were performed since calculations with
noncontinuous longitudinal datasets require a relatively
high number of subjects for adequate power. This was not
the case, nor the objective in this study.
The Zurich cantonal Swiss Veterinary Ofﬁce approved all
the protocols used (i.e., treatment, monitoring, animal hous-
ing) based on the Swiss decree on animal protection. The
protocols are in accordance with the principles and policies
in the Animal Welfare Act and NIHGuide for Care and Use
of Laboratory Animals.
RESULTS
This section presents the results from the corrosion tests,
ﬁbroblast cell tests, and in in vivo rabbit experiments per-
formed to explore biocompatibility and suitability of the
microrobots for implantation.
Corrosion tests
Figure F44 shows typical potentiodynamic polarization curves
for coated and uncoated microrobots. Table T2II presents statis-
tics on corrosion potential Ecorr and corrosion current density
jcorr determined by Tafel analysis. The corrosion potential
Ecorr of Ppy-coated microrobots was signiﬁcantly higher than
that of Au coated (type I) or uncoated microrobots (p-val-
ues<3.71022), which indicates a more “noble” nature of the
surface reacting with HBSS. Also, Ecorr for Au coating type II
was signiﬁcantly higher than that of the uncoated (p val-
ues53.51022). However, the difference between Ecorr of Au
coating type I and II (p values5 6.31021) was statistically
insigniﬁcant at 95% conﬁdence level. All microrobots had
minimal jcorr (i.e., the jcorr values were <3 lAcm22; the mean
jcorr values were <2 lAcm22). The jcorr values indicated that
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FIGURE 3. A: Pars plana injection with 23G needle placement 1 mm peripheral to the internal limbus. A precise needle placement is required to
prevent damage to adjacent tissues. B: Visualization of the needle position within the vitreous cavity through the pupil. C: Ejection of a microro-
bot from the needle tip: 0.1 mL of HA was used to push the microrobot out of the needle tip. D: Successful placement of a microrobot in the
center of the vitreous after retraction of the needle.
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FIGURE 4. Tafel plots of the microrobots tested in HBSS medium:
uncoated CoNi surface (as prepared), electrodeposited Au surface
(Au), and electrodeposited Ppy surface (Ppy).
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there was a lesser release of ions from Au coating type II than
from uncoated microrobots. NB: Ppy is a conducting polymer,
hence current measured (i.e., corresponding current density
4.8360.76 lAcm22) is a sum of corrosion currents and dop-
ing/undoping currents between the microrobot and the HBSS
[see (*) in Table II].
The surface of the microrobots was analyzed by SEM fol-
lowing the potentiodynamic polarization tests. All the micro-
robots preserved their integrity [FigureF5 5(A)], although
some localized features were observed. In particular, a
microcracked surface was noticed for the Ppy-coated micro-
robots [Figure 5(D)]. The cracks typically occur due to the
Ppy doping process.23 Na, Ca, Cl, O, and P elements originat-
ing from the HBSS solution residue [see Figure 5(B)] were
typically detected in the corresponding EDX patterns (data
not shown). Despite the aforementioned features, the sur-
face of the microrobots did not show any traces of Co and
Ni, as proven by XPS analyses (Supporting Information
Figure S2). Hence, the Au coatings completely sealed the
CoNi body from direct contact with HBSS medium. Indeed,
the survey spectrum of the Ppy-coated microtubes was very
similar to that of the as-prepared material.23 C and O were
the main elements detected by XPS at the uttermost surface
in both Au (type I and type II)- and Ppy-coated microtubes.
Additionally, N was detected in the latter. Na, Ca, and P
were detected in small amounts in the Au-coated micro-
tubes by XPS as well. These were likely coming from the
HBSS solution. The oxygen content in the uncoated microro-
bots was found to be low (<4 wt %) by EDX, indicating
that the CoNi alloy did not oxidize extensively. Actually, the
Co/Ni ratio remained the same in both uncoated and coated
robots (38 at% Co, 62 at% Ni). This indicates that no pref-
erential release of Co or Ni ions took place in the former
despite the absence of any protective coating.
TABLE II. Mean and SD Values of Ecorr and jcorr Measured
from the Microrobots.
Microrobot Types
Corrosion
Potential
Ecorr (mV)
Rate of
Corrosion
jcorr (lA cm
22)
Mean SD Mean SD
Uncoated (N5 5) 2327 58 1.46 0.15
Au type I (N5 6) 2264 81 1.92 0.77
Au type II (N5 5) 2214 56 1.12 0.50
Ppy (N5 3) 2145 6 (*) (*)
FIGURE 5. The SEM images shown were taken after the corrosion tests of a Au (type I) coated CoNi microrobot, shown in A. The zoomed details
of the external surface for uncoated (B), Au (type I) coated (C), and Ppy/Au-coated (D) microrobots.
FIGURE 6. Mean values of cell proliferation relative to control with SDs
in error bars (n> 4 samples for each microrobot type; 7 as-prepared
microrobots with a CoNi surface, 4 Au-coated type II microrobots, and 8
Ppy-coated microrobots). 100% corresponds to the mean proliferation of
the cells in the PBS solvent referred to as control (four control samples).
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In vitro ﬁbroblast viability
NIH3T3 ﬁbroblast viability was determined by tetrazolium
conversion that monitors the mitochondrial activity as an
indication of living cells. Cell proliferation relative to control
(Figure F66) was indistinguishable for uncoated microrobots,
coated microrobots, and the control samples. The positive
viability data gained from the in vitro cell culture assay
were the motivation to perform in vivo biocompatibility tri-
als in living rabbit eyes.
In vivo rabbit experiments
A Ppy-coated microrobot was injected with 0.1 mL HA into the
ocular posterior segment (vitreous) of one randomly assigned
eye in six healthy female New Zealand white rabbits (Group
A1) (Figure F77). Six more rabbits received a sham injection of
0.1 mL HA alone (Group B1). The posterior lens capsule was
inadvertently damaged during the injection procedure in the
ﬁrst two eyes receiving a microrobot (Group A1) and in the
ﬁrst two eyes receiving a sham injection (Group B1). As a direct
result of the lens capsule laceration a focal cataract developed
in all of these four eyes. Only minimal inﬂammatory changes
that are potentially related to the lens capsule ruptures were
observed clinically and histopathologically. No study-related
clinical or histopathologic abnormalities were observed in any
of the fellow eyes not receiving injections (Groups A0 and B0).
Clinically, eyes receiving HA sham injections (Group B1)
C
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FIGURE 7. Two typical images from the rabbit eyes one day after injection. A: A microrobot placed in the central part of the vitreous. B: A micro-
robot placed in the posterior part of the vitreous adjacent to the retina.
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FIGURE 8. Inflammatory changes observed in microrobot-implanted
rabbit eyes (n5 6). A: General inflammatory changes in the anterior
segment of the eye. B: Inflammatory changes in the posterior seg-
ment of the eye. The time point t0 is baseline, t1 indicates 4 h after
microrobot injection, and t2 indicates 4 h after microrobot manipula-
tion. Remark: “max5 1–4” refers to the maximal clinical scores
assigned to the various clinical variables that were scored according
to the “Ocular irritation scoring scale based on modified McDonald-
Shadduck score system (Altmann et al.27),” which is provided in
Suporting Information.
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FIGURE 9. Mild limbal lymphoplasmacytic episcleritis in the vicinity of
the injection site observed in all eyes receiving sham injections. This
is a sign of very mild, local injection procedure-related inflammation
in these eyes. Hematoxylin and eosin (H&E) histopathology stain
(Image courtesy R.R.Dubielzig, COPLOW).
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FIGURE 10. A: (1) Baseline examination one day prior to microrobot injection. (2) Optic neuritis (n5 1) at 14 days post microrobot injection in the
same eye as (1). Note the dilation of pre-existing blood vessels on and around the optic nerve head compared to the situation in the same eye at
the baseline examination. B: Complete retinal detachment and optic neuritis at 28 days post microrobot injection. Blood vessel dilation and forma-
tion of new blood vessels are visible at the location of the optic nerve head. The detached retina can be observed as folded membranous structure
that originates at the optic nerve head and fans out toward the periphery. The injected microrobot is visible at the top left side of the image.
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FIGURE 11. All images demonstrate histopathologic changes in eyes post microrobot injection (Images courtesy R.R.Dubielzig, COPLOW).
A: Macroscopic image of a hemisected eye with a microrobot (black linear object) embedded in the vitreous behind the lens. The lens is yellow
as a result of the fixative used to prepare the eye for histopathology. A vitreal traction band extends from the retina toward the microrobot
(black arrow). B: Complete retinal detachment (black arrow). The optic nerve head is indicated by the red arrow. The ocular lens is visible as
oval structure at the top of the image. H&E histopathology stain. This is the same eye as in Figure 10(B). C: A vitreal traction band (black arrow)
at its point of attachment to the retina below. Retinal folds are visible on the right side of this image (red arrow). Periodic acid–Schiff (PAS)
histopathology stain. D: Brown foreign material (black arrow), potentially Ppy coating, in a multinucleated giant cell. This is the same eye as in
Supporting Information Figure S4(C). (H&E histopathology stain).
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showed mild inﬂammatory changes, which subsided within the
ﬁrst 2 weeks after injection (FiguresF8 8). Histopathology
revealed a minimal limbal lymphoplasmacytic episcleritis in
the vicinity of the injection site, which is a sign of very mild,
local injection procedure related inﬂammation in these eyes
(FigureF9 9).
During the ﬁrst week after injection, eyes receiving micro-
robots (Group A1) exhibited mild inﬂammatory changes [Fig-
ure 8(A, B)] similar to those observed in the eyes receiving HA
sham injections [Figures S3(A-C) in Supplementary material].
The changes in the anterior part of the eye predominated and
were interpreted to be a result of the injection procedure
rather than the HA, since HA is a natural part of the vitreous.
Inﬂammatory changes in the posterior segment of ﬁve out of
six eyes receiving microrobots appreared (preretinal cell inﬁl-
trates and optic neuritis) or signiﬁcantly increased (vitreal
cells) during the second week after microrobot implantation
[Figure 8(B) and Supporting Information Figure S3(C)]. One
eye had an optic nerve inﬂammation [FigureF10 10(A)]. A second
eye had a complete and permanent detachment of the retina
[Figure 10(B)]. These two eyes were unresponsive to light. A
partial retinal detachment occurred in four more eyes, which
was temporary in three eyes and permanent for the study
duration in one. A tear or hole in the retina was observed clini-
cally in two eyes. Such ocular changes were not observed in
any of the control groups [Supporting Information Figure
S3(C)]. No obvious obvious surface changes were observed
opthalmoscopically on the microrobots prior to euthanasia
[Supporting Information Figure S4(A, B)], apart from a small
ﬂake of detached Ppy coating could be observed on one of the
microrobots [Supporting Information Figure S4(C)].
By the end of the follow-up, histopathologic studies con-
ﬁrmed that the inﬂammation was accompanied by the presence
of vitreous traction bands (n5 3) [FigureF11 11(A)], retinal wrin-
kling/folding (n5 3) [Figure 11(B)], retinal tear (n5 2), retinal
detachment (n52) [Figure 11(C)], retinal atrophy (n53), or
optic neuritis (n5 1). Histopathologic sections also demon-
strated multinucleated giant cells with phagocytosed brown for-
eign material in one of the rabbit eyes [Figure 11(D)],
corresponding to the eye demonstrated in Supporting Informa-
tion Figure S4(C)]. The microrobot manipulation did not cause
a signiﬁcant increase of inﬂammatory changes apart from
increased scores for conjunctival congestion and iris changes
detected during the three following days [Figure 8(A) and Sup-
porting Information Figure S3(A-B)]. However, the level of
inﬂammation in the vitreous had already reached a signiﬁcant
level by that time [Figure 8(B) and Supporting Information Fig-
ure S3(C)].
DISCUSSION
Steerable ophthalmic microrobots are envisioned in ocular
applications that require implantation. Coated (Au and Ppy)
and uncoated (as-prepared CoNi) microrobots were investi-
gated for their corrosion properties and for cell viability.
The corrosion current density values as measured by poten-
tiodynamic polarization were minimal (i.e., jcorr <3 lAcm22
for uncoated and Au coated; ND: current density of Ppy
<5.5 lAcm22 includes doping/undoping currents). The cor-
rosion potentials showed a trend consistent with the intrin-
sic nobility of the materials. Also, galvanic pairs between
the CoNi alloy and the nobler Au layer that could cause
severe oxidation of the CoNi material in the coated microro-
bots were not observed. This result suggests that Au (type I
and II layers) homogeneously coats the CoNi alloy surface
and exerts some sealing effect [Figure 5(C)].
NIH3T3 ﬁbroblasts cultured in solution, in which coated
or uncoated microrobots were stored for 7 days, were via-
ble and proliferated normally. This ﬁnding indicates that no
cytotoxic compounds were released from the microrobots
into the supernatant after 7 days in solution. This result is
consistent with the low corrosion current densities deter-
mined by electrochemical corrosion analyses.
In vivo tests with implantation in rabbit eyes were per-
formed using Ppy-coated implants. The presence of signiﬁcant
inﬂammatory responses after the second week following
injection can be interpreted to demonstrate the unsuitability
of the microrobots for long-term implantation. A cracked Ppy
surface [Figure 5(D)] used to enhance antibiofouling proper-
ties,23 enlarges the surface area in ocular contact, and there-
fore increases the risk of releasing potentially harmful
sulfonate ions stabilized within the Ppy structure. Also, the
presence of phagocytosed brown foreign material within mul-
tinucleated giant cells in one of the rabbit eyes could indicate
an inﬂammatory reaction to released Ppy [Figure 11(D)],
even though the Ppy has exhibited biocompatibility on sur-
face.23 Rabbit eyes have been found among the most sensitive
in vivo models,28,29 which could explain the severity of the
responses observed. The absence of signiﬁcant inﬂammatory
responses during the entire ﬁrst week following injection
motivates to continue investigating coated microrobots for
implantation. Whether the uninﬂamed state of the eyes can
be preserved with timely removal of the microrobots needs to
be conﬁrmed in an implantation—explantation study setup. A
careful in vivo biocompatibility characterization should be
carried out if Ppy is intended for an ophthalmic application.
The presented results provide valuable information for those
who work on implant technology and biocompatibility. The
future capability for microrobot implantation can realize the
potential to enable a new generation of surgical,5,8,9 targeted
drug delivery4,9,11,12 and diagnostic7 techniques involving
implantation in the posterior segment of the eye.
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